Korea South
BTGin Co., Ltd. is a Korean biotechnology startup that specializes in the development and production of ginseng products. Founded in 2002 and headquartered in Daejeon, Korea, the company has positioned itself as a pioneer in utilizing ginseng for pharmaceutical and nutraceutical purposes. With a focus on ginsenosides, BTGin has developed proprietary technology for the transformation and mass production of over 30 pure single ginsenosides, catering to the increasing demand in the global ginseng trade market.
As the pharmaceutical potential of ginseng and ginsenosides gains recognition, BTGin has strategically invested in enzyme technology to produce new ginsenosides and enhance the effectiveness of ginseng components. In addition to its manufacturing capabilities, the company also possesses in-house technology for quality assessment of ginseng products and the production of glyco-products, including functional food and cosmetic materials.
BTGin Co., Ltd. is shaping its identity around the ethos of "Creation of unlimited value through free competition," positioning itself as a leader in biotechnology. With the increasing global demand for ginseng-based products, the company's strong technological foundation and focus on innovation present promising opportunities for future growth and market leadership.
